AquaBounty Technologies (AQB) had the highest return between January 3, 2017 and February 25, 2017 by a US stock, returning 192,955.6%.
| ASSET | DATE | % RETURN |
|---|---|---|
AquaBounty Technologies (AQB) | 1/3/2017 - 2/25/2017 | 192,955.56% |
Ocean Power Technologies (OPTT) | 1/3/2017 - 2/25/2017 | 1,658.39% |
Pulmatrix (PULM) | 1/3/2017 - 2/25/2017 | 639.29% |
Gravity (GRVY) | 1/3/2017 - 2/25/2017 | 222.71% |
Ryvyl (RVYL) | 1/3/2017 - 2/25/2017 | 202.61% |
authID (AUID) | 1/3/2017 - 2/25/2017 | 191.67% |
Duos Technologies (DUOT) | 1/3/2017 - 2/25/2017 | 185.71% |
Castellum (CTM) | 1/3/2017 - 2/25/2017 | 163.16% |
Coda Octopus (CODA) | 1/3/2017 - 2/25/2017 | 156.99% |
Viridian Therapeutics (VRDN) | 1/3/2017 - 2/25/2017 | 154.47% |
Matinas BioPharma (MTNB) | 1/3/2017 - 2/25/2017 | 141.01% |
Protalix Biotherapeutics (PLX) | 1/3/2017 - 2/25/2017 | 133.28% |
Versus Systems Inc. (VS) | 1/3/2017 - 2/25/2017 | 133.19% |
Pulse Biosciences (PLSE) | 1/3/2017 - 2/25/2017 | 124.46% |
DSS (DSS) | 1/3/2017 - 2/25/2017 | 110.95% |
Cronos (CRON) | 1/3/2017 - 2/25/2017 | 105.88% |
Aehr Test Systems (AEHR) | 1/3/2017 - 2/25/2017 | 102.99% |
Quantum Computing (QUBT) | 1/3/2017 - 2/25/2017 | 100% |
Netcapital (NCPL) | 1/3/2017 - 2/25/2017 | 100% |
Mogo (MOGO) | 1/3/2017 - 2/25/2017 | 96.62% |
NextTrip (NTRP) | 1/3/2017 - 2/25/2017 | 96.02% |
Galectin Therapeutics (GALT) | 1/3/2017 - 2/25/2017 | 95.88% |
Applied Opt (AAOI) | 1/3/2017 - 2/25/2017 | 93.93% |
Quoin Pharmaceuticals Ltd DRC (QNRX) | 1/3/2017 - 2/25/2017 | 92.48% |
Esperion Therapeutics (ESPR) | 1/3/2017 - 2/25/2017 | 89.77% |
